Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

[Evidence-based cardiology: practical applications from epidemiology. II. The use of biomarkers].

Trejo-Gutiérrez JF, López-Jiménez F.

Arch Cardiol Mex. 2011 Apr-Jun;81(2):158-61. Spanish.

PMID:
21775250
2.

Vitamin D and cardiovascular disease risk.

Michos ED, Melamed ML.

Curr Opin Clin Nutr Metab Care. 2008 Jan;11(1):7-12. Review.

PMID:
18090651
3.

[Vitamin D status and disease--hasty conclusions?].

Lindseth I, Konradsen S, Meyer IF.

Tidsskr Nor Laegeforen. 2009 Sep 24;129(18):1896-8. doi: 10.4045/tidsskr.08.0437. Norwegian. No abstract available.

4.

Hypovitaminosis D correction and high-sensitivity C-reactive protein levels in hypertensive adults.

Carlson N, Mah R, Aburto M, Peters MJ, Dupper MV, Chen LH.

Perm J. 2013 Fall;17(4):19-21. doi: 10.7812/TPP/13-007.

5.

[Vitamin D and cardiovascular disease: epidemiological aspects].

Guessous I, Bochud M.

Rev Med Suisse. 2012 Oct 31;8(360):2059-60, 2062-5. French.

PMID:
23185927
6.

Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up.

Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jenssen T, Njølstad I, Schirmer H, Jorde R.

Diabet Med. 2010 Oct;27(10):1107-15. doi: 10.1111/j.1464-5491.2010.03092.x.

PMID:
20854377
7.

Plasma 25-hydroxyvitamin D, hormonal contraceptive use, and cardiometabolic disease risk in an ethnically diverse population of young adults.

García-Bailo B, Karmali M, Badawi A, El-Sohemy A.

J Am Coll Nutr. 2013;32(5):296-306. doi: 10.1080/07315724.2013.826112.

PMID:
24219372
8.

Double treatment with paricalcitol-associated calcifediol and cardiovascular risk biomarkers in haemodialysis.

Piñera-Haces C, Izquierdo-Ortiz MJ, Martín-de Francisco ÁL, García-Unzueta MT, López-Hoyos M, Toyos C, Allende N, Quintela E, Arias M.

Nefrologia. 2013 Jan 18;33(1):77-84. doi: 10.3265/Nefrologia.pre2012.Sep.11533. English, Spanish.

9.

Association between vitamin D status and markers of vascular health in patients with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).

Witham M, Kennedy G, Belch J, Hill A, Khan F.

Int J Cardiol. 2014 Jun 1;174(1):139-40. doi: 10.1016/j.ijcard.2014.03.145. Epub 2014 Apr 2. No abstract available.

PMID:
24726169
10.

Genetic variation in the vitamin D receptor, plasma 25-hydroxyvitamin D, and biomarkers of cardiometabolic disease in Caucasian young adults.

García-Bailo B, Jamnik J, Da Costa LA, Badawi A, El-Sohemy A.

J Nutrigenet Nutrigenomics. 2013;6(4-5):256-67. doi: 10.1159/000354729. Epub 2013 Sep 27.

PMID:
24081327
11.

[CRP level as risk marker of cardiovascular disease?].

Thelle DS, Arnesen E.

Tidsskr Nor Laegeforen. 2010 Mar 11;130(5):512-4. doi: 10.4045/tidsskr.09.1002. Norwegian. No abstract available.

12.

Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?

Anderson JL, Vanwoerkom RC, Horne BD, Bair TL, May HT, Lappé DL, Muhlestein JB.

Am Heart J. 2011 Aug;162(2):331-339.e2. doi: 10.1016/j.ahj.2011.05.005.

PMID:
21835295
13.

Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases?

Debreceni B, Debreceni L.

Cardiovasc Ther. 2012 Aug;30(4):227-33. doi: 10.1111/j.1755-5922.2011.00266.x. Epub 2011 Apr 1. Review.

PMID:
21884001
14.

[Evidence-based cardiology: practical applications from epidemiology. IV Cardiovascular risk prediction].

Rodríguez-Escudero JP, López-Jiménez F, Trejo-Gutiérrez JF.

Arch Cardiol Mex. 2012 Jan-Mar;82(1):66-72. Spanish.

PMID:
22452869
15.

Calcium, vitamin D and cardiovascular disease.

Guessous I, Bochud M, Bonny O, Burnier M.

Kidney Blood Press Res. 2011;34(6):404-17. doi: 10.1159/000328332. Epub 2011 Jun 11. Review.

16.

Vitamin E and heart disease: basic science to clinical intervention trials.

Pryor WA.

Free Radic Biol Med. 2000 Jan 1;28(1):141-64. Review.

PMID:
10656300
17.

Health effects of vitamin D.

Bischoff-Ferrari H.

Dermatol Ther. 2010 Jan-Feb;23(1):23-30. doi: 10.1111/j.1529-8019.2009.01288.x. Review.

PMID:
20136906
18.

Vitamin D and cardiovascular disease - dilemma, delight or 'dont know?'.

Viljoen A.

Int J Clin Pract. 2013 Oct;67(10):939-42. doi: 10.1111/ijcp.12197.

PMID:
24073970
19.

Does inconclusive evidence for vitamin D supplementation to reduce risk for cardiovascular disease warrant pessimism?

Grant WB.

Ann Intern Med. 2010 Aug 3;153(3):209; author reply 209-10. doi: 10.7326/0003-4819-153-3-201008030-00017. No abstract available.

PMID:
20679570
20.

Does inconclusive evidence for vitamin D supplementation to reduce risk for cardiovascular disease warrant pessimism?

Plotnikoff GA.

Ann Intern Med. 2010 Aug 3;153(3):208; author reply 209-10. doi: 10.7326/0003-4819-153-3-201008030-00015. No abstract available.

PMID:
20679568

Supplemental Content

Support Center